China Cord Blood Corporation
|
Ordinary Shares, par value $0.0001
|
G21107100
|
Yuen Kam
48th Floor, Bank of China Tower,
1 Garden Road, Central,
Hong Kong S.A.R.
(852) 3605-8180
|
Mitchell S. Nussbaum, Esq.
Loeb & Loeb LLP
345 Park Avenue
New York, NY10154
(212) 407-4159
|
September 27, 2011
|
CUSIP No. G21107100
|
SCHEDULE 13D/A
|
|||
1
|
NAME OF REPORTING PERSON
Golden Meditech Stem Cells (BVI) Company Limited
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
OO
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
¨
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
|
|||
7
|
SOLE VOTING POWER
30,119,626
|
|||
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
|
8
|
SHARED VOTING POWER
-0-
|
||
9
|
SOLE DISPOSITIVE POWER
30,119,626
|
|||
10
|
SHARED DISPOSITIVE POWER
-0-
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,119,626
|
|||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
40.9% (1)
|
|||
14
|
TYPE OF REPORTING PERSON
CO
|
|
(1)
|
Based upon 73,663,614 ordinary shares outstanding as of September 28, 2011, as disclosed in the Issuer’s Form 20-F filed with the Securities and Exchange Commission on September 28, 2011.
|
CUSIP No. G21107100
|
SCHEDULE 13D/A
|
|||
1
|
NAME OF REPORTING PERSON
Golden Meditech Holdings Limited
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨
|
|||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
¨
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
|
|||
7
|
SOLE VOTING POWER
30,119,626
|
|||
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
|
8
|
SHARED VOTING POWER
-0-
|
||
9
|
SOLE DISPOSITIVE POWER
30,119,626
|
|||
10
|
SHARED DISPOSITIVE POWER
-0-
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,119,626
|
|||
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
40.9% (1)
|
|||
14
|
TYPE OF REPORTING PERSON
CO
|
|
(1)
|
Based upon 73,663,614 ordinary shares outstanding as of September 28, 2011, as disclosed in the Issuer’s Form 20-F filed with the Securities and Exchange Commission on September 28, 2011.
|
Date of
Transaction
|
Number of
Shares
|
Price Per
Shares
|
Type of Transaction
|
21/9/2011
|
25,459
|
3.00
|
Open Market (NYSE)
|
22/9/2011
|
200,000
|
3.00
|
Open Market (NYSE)
|
27/9/2011
|
50,000
|
2.80
|
Open Market (NYSE)
|
GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED
|
|||
|
By:
|
/s/ Kam Yuen | |
Name: Kam Yuen | |||
Title: Director | |||
GOLDEN MEDITECH HOLDINGS LIMITED
|
|||
|
By:
|
/s/ Kam Yuen | |
Name: Kam Yuen | |||
Title: Chairman and Chief Executive Officer | |||